Nkarta, a US biopharma developing engineered natural killer (NK) cell therapies to treat cancer, has announced the appointment of a chief medical officer (CMO). 11 January 2023
US cancer specialist Spectrum Pharmaceuticals has lost more than 50% of its stock market value in the past six months, and it has now lost a member of its belea 4 January 2023
CAR-T therapy company Allogene Therapeutics has swiftly named its replacement for executive vice president of research and development Rafael Amado, who has res 3 January 2023
Sir Mike Rawlins, a UK pharmacologist who made a massive impact in the field of medicines reimbursement in his own country and internationally, has died at the 3 January 2023
French drug resistance specialist Ribonexus has appointed Steven Powell as chief executive, as the company prepares to seek more financing for its small molecul 14 December 2022
The retiring Paul Perreault is to be replaced by another Paul as chief executive and managing director of Australian biotech CSL Limited. 13 December 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.